Alto Neuroscience, Inc.
Alto Neuroscience, Inc. (ANRO) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
ANRO · net income · updated Jun 10, 2026
Core profitability metrics
ANRO · net income · margin · TTM · CAGRNet income was −$63.2M for FY2025 (fiscal year ending 2025-12-31), down 2.9% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · ANRO net income history · ANRO profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Alto Neuroscience, Inc. (ANRO) reported net income of −$63.2M for FY2025 (fiscal year ending 2025-12-31), down 2.9% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Alto Neuroscience, Inc. has not yet achieved annual profitability based on available data (5 fiscal years). The company has reported net losses across all available periods.
Alto Neuroscience, Inc.'s net profit margin was — for FY2025, based on the latest annual results.
Investors sometimes search for "Alto Neuroscience, Inc. net worth" — the company's market capitalization is a separate figure from ANRO net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
ANRO net income · 4 questionsAlto Neuroscience, Inc. is not currently profitable on an annual basis. The company reported a net loss of $63.2M for FY2025.
▸ Source: FMP /income-statement · GAAP · Alto Neuroscience, Inc. · Alto Neuroscience, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 10, 2026